Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 71

Results For "Act"

7904 News Found

Dr. Saurabh Lall joins KIMS Hospitals as Chief Operating Officer
People | June 04, 2026

Dr. Saurabh Lall joins KIMS Hospitals as Chief Operating Officer

Dr. Lall brings extensive experience in healthcare operations, business strategy, and hospital management


Ipca Laboratories appoints Dr. Sandarbh Rishi as Head – MSAT/Pilot Plant
People | June 04, 2026

Ipca Laboratories appoints Dr. Sandarbh Rishi as Head – MSAT/Pilot Plant

Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations


TDB supports Indigenous production of green pharma ingredients
News | June 04, 2026

TDB supports Indigenous production of green pharma ingredients

Chennai based Bioneemtec India has received support from Technology Development Board for commercializing indigenous green chemistry technologies to produce critical pharmaceutical ingredients


ResMed acquires Noctrix Health for $340 million
Medical Device | June 04, 2026

ResMed acquires Noctrix Health for $340 million

Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio


India’s medical devices sector is poised for a pharma-like transformation:  Pranav Sharma, SBU Head - Advanced Surgery, Healthium MedTech
interviews | June 03, 2026

India’s medical devices sector is poised for a pharma-like transformation: Pranav Sharma, SBU Head - Advanced Surgery, Healthium MedTech

The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases


Akums secures European CEP approval for Cefpodoxime Proxetil
Drug Approval | June 03, 2026

Akums secures European CEP approval for Cefpodoxime Proxetil

The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner


Servier to acquire Edgewise muscular dystrophy business in $2.65 billion deal
News | June 03, 2026

Servier to acquire Edgewise muscular dystrophy business in $2.65 billion deal

The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments


Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6
News | June 03, 2026

Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6

First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept


Granules Pharmaceuticals receives USFDA EIR for Chantilly facility
News | June 03, 2026

Granules Pharmaceuticals receives USFDA EIR for Chantilly facility

This facility plays an important role in Granules’ global manufacturing and supply network


Intracin Pharma secures APVMA nod to supply veterinary medicines in Australia
News | June 03, 2026

Intracin Pharma secures APVMA nod to supply veterinary medicines in Australia

Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market